Evidence map›Paper›PMID 28940494›Full record

ArticleJournal of applied microbiology2017

16S rRNA gene sequencing on a benchtop sequencer: accuracy for identification of clinically important bacteria.

G S Watts, K Youens-Clark, M J Slepian, D M Wolk, M M Oshiro, G S Metzger, D Dhingra, L D Cranmer, B L Hurwitz

Abstract readValidation Study
In one paragraph

Article in Journal of applied microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Changes in the fecal microbiota of breast cancer patients based on 16S rRNA gene sequencing: a systematic review and meta-analysis.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2024
    Pooled it
  2. Pooled it
  3. Article
  4. Biodiversity and Natural Product Potential of Indonesian Actinomycetes.Journal of microbiology and biotechnology · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Preliminary profile of the gut microbiota from amerindians in the Brazilian amazon experiencing a process of transition to urbanization.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

G S WattsThe University of Arizona Cancer Center, University of Arizona, Tucson, AZ, USA.ORCID http://orcid.org/0000-0001-8216-0144
K Youens-ClarkDepartment of Agricultural and Biosystems Engineering, University of Arizona, Tucson, AZ, USA.
M J SlepianDepartment of Medicine, University of Arizona, Tucson, AZ, USA.
D M WolkPharmaceutical Sciences, Geisinger Health System, Danville, PA, USA.
M M OshiroThe University of Arizona Cancer Center, University of Arizona, Tucson, AZ, USA.
G S MetzgerThe University of Arizona Cancer Center, University of Arizona, Tucson, AZ, USA.
D DhingraLife Technologies, Thermo Fisher Scientific, Carlsbad, CA, USA.
L D CranmerSchool of Medicine, Seattle, WA, USA.
B L HurwitzDepartment of Agricultural and Biosystems Engineering, University of Arizona, Tucson, AZ, USA.

Funding

VITAMIN AP30CA023074 · NCI · UNIVERSITY OF ARIZONA · PI Dan Theodorescu · 1985 to 2026
$110.2M
SOUTHWEST ENVIRONMENTAL HEALTH SCIENCES CENTERP30ES006694 · NIEHS · UNIVERSITY OF ARIZONA · PI DEAN BILLHEIMER · 1994 to 2026
$36.7M
NCI NIH HHS P30 CA023074NIEHS NIH HHS P30 ES006694
6 · The paper itself

Abstract

aimsTest the choice of 16S rRNA gene amplicon and data analysis method on the accuracy of identification of clinically important bacteria utilizing a benchtop sequencer. METHODS AND

resultsNine 16S rRNA amplicons were tested on an Ion Torrent PGM to identify 41 strains of clinical importance. The V1-V2 region identified 40 of 41 isolates to the species level. Three data analysis methods were tested, finding that the Ribosomal Database Project's SequenceMatch outperformed BLAST and the Ion Reporter Metagenomics analysis pipeline. Lastly, 16S rRNA gene sequencing mixtures of four species through a six log range of dilution showed species were identifiable even when present as 0·1% of the mixture.

conclusionsSequencing the V1-V2 16S rRNA gene region, made possible by the increased read length Ion Torrent PGM sequencer's 400 base pair chemistry, may be a better choice over other commonly used regions for identifying clinically important bacteria. In addition, the SequenceMatch algorithm, freely available from the Ribosomal Database Project, is a good choice for matching filtered reads to organisms. Lastly, 16S rRNA gene sequencing's sensitivity to the presence of a bacterial species at 0·1% of a mixture suggests it has sufficient sensitivity for samples in which important bacteria may be rare. SIGNIFICANCE AND IMPACT OF THE STUDY: We have validated 16S rRNA gene sequencing on a benchtop sequencer including simple mixtures of organisms; however, our results highlight deficits for clinical application in place of current identification methods.

Indexed as

BacteriaBase SequenceRNA, Ribosomal, 16SSequence Analysis, DNARNA, Ribosomal, 16S16S rRNA geneaccuracybacterial identificationbenchtop sequencersensitivity

Identifiers

PMID28940494
PMCPMC5765505

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.